• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

DF/HCC News

    National Cancer Institute Awards $26.3 Million to Establish Seven Centers of Cancer Nanotechnology Excellence

    October 3, 2005 - The National Cancer Institute (NCI), part of the National Institutes of Health NIH), announced the implementation of a major component of its $144.3 million five-year initiative for nanotechnology in cancer research

    Gene Expression Profile Helps Predict Chemotherapy Response In Ovarian Cancer Patients

    BOSTON - A newly identified gene expression profile could help predict how patients with advanced ovarian cancer will respond to chemotherapy treatment

    When Does a Mole Become a Melanoma?

    February 7, 2005 - Researchers at Children's Hospital Boston and the Dana-Farber Cancer Institute have found an important clue about the origins of the deadly skin cancer melanoma

    MicroRNA Study Opens Potential Revolution in Cancer Diagnosis

    Despite significant progress in understanding the genetic changes in many different cancers, diagnosis and classification of the tumor type remain, at best, an imperfect art. This could change quickly, thanks to the recent findings of a group of researchers. For more information, visit ..

    Breast Tumor's Biological Traits Guide Hormone Therapy

    The characteristics of an individual patient's breast cancer can help physicians choose the most effective treatment sequence with tamoxifen and the newer aromatase inhibitors, according to a study ledy by researchers from Dana-Farber Cancer Institute in Boston

Displaying results 204 to 208 out of 208